Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Methamphetamine-dependence: early-phase trial registry
6 of 19 indexed Methamphetamine-dependence trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #902 of 28,707 conditions by registered trial count.
19 US clinical trials · 6 currently recruiting · #902 of 28,707 conditions by registered trial count
Methamphetamine-dependence: 19 US clinical trials tracked, 6 recruiting.
Methamphetamine-dependence is the subject of 19 registered US clinical trials on ClinicalTrials.gov, 6 of them currently open to new participants. 2 are in Phase 3-4 (later-stage) and 10 in Phase 1-2 (earlier-stage). The most active sponsor is University of California, Los Angeles, running 4 of these trials.
Enrollment posture brief
Registry condition methamphetamine-dependence
OPEN 6 | RECR 32% | LATE 2 | EARLY 10 | RANK #902 | SPON 4
Volume-matched condition peers
Nearest open-share peer: Back Pain (32% recruiting · 38 trials)
Methamphetamine-dependence lists 6 open slots (32% of 19 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Methamphetamine-dependence on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Methamphetamine-dependence is recruiting below its size-band peers.
6 of 19 indexed trials (31.6%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Methamphetamine-dependence research.
University of California, Los Angeles accounts for 4 of 19 trials (21.1%). 13 distinct sponsors appear on at least one study for this condition label.
-
Most Methamphetamine-dependence trials plan to enrol fewer than 100 people.
Median target enrolment is 30 among the 19 trials that report a genuine target (sentinel values excluded). 15 of those (78.9%) plan for fewer than 100 participants.
-
Methamphetamine-dependence research is mostly interventional.
18 interventional and 1 observational studies make up this index (94.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
19 total, page 1 of 1
Encouraging Abstinence Behavior in a Drug Epidemic: Optimizing Dynamic Incentives
Wake Forest University Health Sciences
NCT04927143
Trial of Naltrexone/Bupropion for the Treatment of Methamphetamine Use Disorder
National Institute on Drug Abuse (NIDA)
NCT06233799
Enhanced Digital-Chemosensory-Based Olfactory Training for Remote Management of Substance Use Disorders
Evon Medics
NCT06434818
rTMS for Craving in Methamphetamine Use Disorder
Oregon Health and Science University
NCT03470480
PRevention Of Methamphetamine Use Among Postpartum Women Trial (PROMPT)
University of Utah
NCT05128071
Creatine for Depressed Male and Female Methamphetamine Users
Montana State University
NCT02568878
MHealth Incentivized Adherence Plus Patient Navigation
University of Washington
NCT06027814
The Human Stress Response in a Simulated ED Setting
University of Arkansas
NCT04317482
Inflammation in Methamphetamine and STIs (IMSTI)
University of California, Los Angeles
NCT05162391
Phase 2, Multi-Center Trial of Modafinil for Methamphetamine Dependence
National Institute on Drug Abuse (NIDA)
NCT00520286
Study of Medical Treatment for Methamphetamine Addiction
University of California, Los Angeles
NCT00833443
PHASE IIA: Trial of a Novel Ondansetron Formulation (OND-PR002) and Immediate-Release Methylphenidate (Ritalin®)(OND003IND)
Tong Lee
NCT01377662
Targeting GABA and Opioid Systems for a Pharmacotherapy for Methamphetamine Abuse
University of Kentucky
NCT01967381
A Trial of Long-Acting Injectable Risperidone in the Treatment of Methamphetamine Dependence
Seattle Institute for Biomedical and Clinical Research
NCT00284206
Varenicline vs Placebo for the Treatment of Methamphetamine Dependence
University of California, Los Angeles
NCT01011829
Pilot TMS for Methamphetamine Use Disorder
Ryan M. Carnahan
NCT04449055
Safety Interaction Trial Ibudilast and Methamphetamine
University of California, Los Angeles
NCT01217970
Buspirone as a Candidate Medication for Methamphetamine Abuse
University of Kentucky
NCT01843205
Characterizing Methamphetamine Withdrawal in Recently Abstinent Methamphetamine Users: A Pilot Study
University of Arkansas
NCT00653263
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 4 |
| Phase 2 | 6 |
| Phase 3 | 2 |
Top Sponsors
Named interventions
Most-linked intervention names on Methamphetamine-dependence records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Methamphetamine-dependence trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Methamphetamine-dependence page
19 registered trials, 6 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 6 Methamphetamine-dependence trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- University of California, Los Angeles sponsors the most Methamphetamine-dependence trials on record, review their full trial history before evaluating a specific study. See University of California, Los Angeles's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Methamphetamine-dependence condition card totals 19 registered trials; most-linked intervention Placebo; top US site state California. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.